Additional studies, which will further confirm the clinical utility of tigecycline in the management of serious infections, are ongoing.
其他的研究，将进一步证明替加环素将在临床上用于治疗严重感染。
2
Tigecycline is a glycylcycline antibiotic that was developed by Wyeth in response to the worldwide threat of emerging resistance to antibiotics.
替加环素，是惠氏公司为解决新出现的、危及全球的抗生素耐药性而研制的一种甘酰胺环素类抗生素。
3
NDM-1 was mostly found among Escherichia coli (36) and Klebsiella pneumoniae (111), which were highly resistant to all antibiotics except to tigecycline and colistin.